0.94
Schlusskurs vom Vortag:
$0.962
Offen:
$0.95
24-Stunden-Volumen:
68,096
Relative Volume:
0.55
Marktkapitalisierung:
$3.98M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.0943
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
-7.84%
1M Leistung:
-26.56%
6M Leistung:
-66.31%
1J Leistung:
-90.36%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Vergleichen Sie SXTP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SXTP
60 Degrees Pharmaceuticals Inc
|
0.94 | 4.07M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - Daytona Beach News-Journal
60 Degrees Pharmaceuticals Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Leesburg Daily Commercial
Gains Report: Can 60 Degrees Pharmaceuticals Inc stock maintain growth trajectory2025 Analyst Calls & Technical Pattern Based Signals - BỘ NỘI VỤ
Day Trade: Why 60 Degrees Pharmaceuticals Inc stock is considered a top pickJuly 2025 Rallies & Stock Portfolio Risk Management - BỘ NỘI VỤ
Can 60 Degrees Pharmaceuticals Inc. stock maintain growth trajectoryMarket Trend Review & Daily Stock Momentum Reports - Newser
Is 60 Degrees Pharmaceuticals Inc Equity Warrant a good long term investmentReal-Time Stock Alerts & Rapid Capital Trading Tips - earlytimes.in
Will 60 Degrees Pharmaceuticals Inc. stock deliver long term returnsNew Guidance & Weekly Breakout Opportunity Watchlist - BỘ NỘI VỤ
What You Should Know About Kohinoor Foods Limiteds Profitability RatiosMarket Volatility Update & Small Investment Portfolio - earlytimes.in
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given New $2.80 Price Target at Ascendiant Capital Markets - Defense World
Why 60 Degrees Pharmaceuticals Inc. stock is considered a top pickLayoff News & Smart Swing Trading Alerts - BỘ NỘI VỤ
Dick's Sporting Goods To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Ascendiant Capital Maintains 60 Degrees Pharmaceuticals (SXTP) Buy Recommendation - Nasdaq
Is 60 Degrees Pharmaceuticals Inc. stock a defensive play in 20252025 Top Gainers & Capital Efficient Trading Techniques - BỘ NỘI VỤ
How 60 Degrees Pharmaceuticals Inc. stock reacts to job market dataMarket Performance Report & Daily Stock Trend Watchlist - BỘ NỘI VỤ
60 Degrees Pharmaceuticals Inc. (SXTP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
60 Degrees Pharma begins enrollment for chronic babesiosis study By Investing.com - Investing.com Nigeria
60 Degrees Pharma begins enrollment for chronic babesiosis study - Investing.com India
60 Degrees Pharmaceuticals announces clinical site now open for patient enrollment - MarketScreener
60 Degrees Pharmaceuticals Launches First-Ever Study for Tafenoquine in Chronic Babesiosis Patients - Quiver Quantitative
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine - The Manila Times
60 Degrees Pharmaceuticals Announces Clinical Site Now Open - GlobeNewswire
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock reach all time highs in 2025 - newser.com
How resilient is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock in market downturnsPortfolio Return Report & Low Volatility Stock Recommendations - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock supported by innovation pipeline2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Upgraded at Zacks Research - Defense World
How 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performs in high volatility markets2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant see short term momentumPortfolio Update Report & High Yield Stock Recommendations - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock sustain free cash flow growthJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com
Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investors2025 Volatility Report & Expert Curated Trade Setups - newser.com
What technical charts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant stockWeekly Trade Recap & Weekly Breakout Watchlists - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain operating margins2025 Trading Volume Trends & Safe Entry Zone Tips - newser.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
How to integrate 60 Degrees Pharmaceuticals Inc. Equity Warrant into portfolio analysis toolsSell Signal & AI Enhanced Trade Execution Alerts - newser.com
60 Degrees Pharmaceuticals Faces Financial Challenges Amid Growth Efforts - MSN
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):